OR WAIT null SECS
March 18, 2020
An NIH study of a COVID-19 vaccine is enrolling Seattle-based healthy adult volunteers.
March 02, 2020
Thermo Fisher Scientific launched the ALPS 5000 Plate Sealer to simplify the plate sealing process and provide enhanced dependability and productivity for stand-alone and integrated robotic projects.
Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?
February 06, 2020
Quick approval pathways challenge teams to balance compliance with the need for speed.
February 05, 2020
Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.
January 22, 2020
Mereo BioPharma Group and Oncologie have entered a global licensing agreement for the development and commercialization of navicixizumab.
January 08, 2020
PhoreMost, a biopharma company based in the United Kingdom, and Boehringer Ingelheim have entered into a multi-project drug discovery collaboration agreement, it was revealed.
December 12, 2019
Swiss-based specialist pharma R&D company, MetP Pharma, has been granted a Notice of Allowance from the Unites States Patent and Trademark Office (USPTO) for its patent titled, “Treatment of Demyelineating Diseases.”
November 14, 2019
A simulation-based drug discovery company, Turbine, has announced the closing of an institutional funding round worth EUR 3 million (US $3.3 million), which will be used to redesign the oncology drug discovery process.
October 24, 2019
Takeda Pharmaceutical Company has acquired an exclusive global license from COUR Pharmaceuticals for the development and commercialization of an investigational celiac disease therapy.